9/29/2023  5:35:30 PM Chg. +1.02 Volume Bid5:36:11 PM Ask5:35:30 PM Market Capitalization Dividend Y. P/E Ratio
101.58EUR +1.01% 790,263
Turnover: 41.1 mill.
-Bid Size: - -Ask Size: - 127.04 bill.EUR 3.51% 15.17

Business description

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Management board & Supervisory board

Paul Hudson
Management board
Jean-Baptiste Chasseloup de Chatillon, Bill Sibold, Brendan O’Callaghan, Julie Van Ongevalle, Natalie Bickford, Olivier Charmeil, Roy Papatheodorou, Thomas Triomphe
Supervisory board
Serge Weinberg, Barbara Lavernos, Ceng-Yann Tran, Christophe Babule, Diane Souza, Fabienne Lecorvaisier, Gilles Schnepp, Lise Kingo, Patrick Kron, Paul Hudson, Rachel Duan, Thomas Südhof, Wolfgang Laux, Carole Ferrand, Emile Voest, Antoine Yver, Frédéric Oudéa

Company data

Name: Sanofi S.A.
Address: 54, Rue La Boétie,F-75008 Paris
Phone: +33-1-53-77-40-00
Fax: +33-1-53-77-43-03
E-mail: -
Internet: https://www.sanofi.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 88.70%
IPO date: -

Investor relations

Name: George Grofik
IR phone: +33-1-53-77-45-45
IR Fax: -
IR e-mail: investor.relations@sanofi.com

Company calendar

CW 43 | 10/27/2023 Interim Report 3rd Quarter/9 Months

Main Shareholders

Non-French institutional
French institutional
Individual shareholders